Numazu
Japan
6
2023-08-31
6
2025-03-04
These are the the leading inventors for applications assigned to CanBas Co., Ltd.:
CanBas Co., Ltd. based in Numazu, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Phosphatidylserine-binding conjugates
#2 | 2017-04-27 ✅ Patent 10,149,887 granted on 2018-12-11Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
#3 | 2011-04-21 ✅ Patent 8,415,357 granted on 2013-04-09Compounds with anti-cancer activity
#4 | 2006-02-07 ✅ Patent 6,995,135 granted on 2006-02-07Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
#5 | 2005-04-19 ✅ Patent 6,881,575 granted on 2005-04-19Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
#6 | 2005-03-17 ✅ Patent 7,851,592 granted on 2010-12-14Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
Also check out CANBAS CO., LTD.'s (Numazu, Japan) applicant profile with 1 patent applications submitted.
199965 ⎘